The Society’s Clinical Affairs Committee oversees clinical guidance by prioritizing topics, selecting authors, and reviewing and approving each document before it is submitted for publication in Contraception.
Clinical Guidance
The Society serves as the home to the Implant Removal Centers of Experience Initiative, which aims to increase timely access to difficult and non-palpable contraceptive implant removal by defining, identifying, and connecting clinicians and implant users to Centers of Experience (COEs) within the US.
The Clinical Affairs Committee’s procedures and the types of clinical guidance produced by the Society is available in our author instructions.
Suggest a topic for new clinical guidance.
Rh testing and administration is no longer recommended prior to 12 weeks gestation for patients undergoing spontaneous, medication, or procedural abortion.
Misoprostol-only medication abortion regimens are safe and effective across a range of gestational durations.